Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Survodutide has a novel mechanism of action (agonism of the dual GCG/GLP-1 receptors) that may have direct effects on energy expenditure in the liver in addition to decreasing appetite
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Subscribe To Our Newsletter & Stay Updated
